Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin with ICS/LABA in Non-eosinophilic Chest Tightness Variant Asthma
NCT05596721Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin in asthma (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Revised Asthma Control Questionnaire at 12 weeks. Status: unknown.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05596721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05596721.